Recombinant Cytokines Drug Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1553179 No. of Pages: 128 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Cytokines are a broad and loose category of small proteins (~5–20 kDa) that are important in cell signaling. Cytokines are peptides, and cannot cross the lipid bilayer of cells to enter the cytoplasm. Cytokines have been shown to be involved in autocrine signaling, paracrine signaling and endocrine signaling as immunomodulating agents. Their definite distinction from hormones is still part of ongoing research. Cytokines include chemokines, interferons, interleukins, lymphokines, and tumour necrosis factors, but generally not hormones or growth factors (despite some overlap in the terminology). Cytokines are produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T lymphocytes and mast cells, as well as endothelial cells, fibroblasts, and various stromal cells; a given cytokine may be produced by more than one type of cell.
Some cytokines have been developed into protein therapeutics using recombinant DNA technology. Recombinant cytokines being used as drugs as of 2014 include:
Bone morphogenetic protein (BMP), used to treat bone-related conditions
Erythropoietin (EPO), used to treat anemia
Granulocyte colony-stimulating factor (G-CSF), used to treat neutropenia in cancer patients
Granulocyte macrophage colony-stimulating factor (GM-CSF), used to treat neutropenia and fungal infections in cancer patients
Interferon alfa, used to treat hepatitis C and multiple sclerosis
Interferon beta, used to treat multiple sclerosis
Interleukin 2 (IL-2), used to treat cancer.
Interleukin 11 (IL-11), used to treat thrombocytopenia in cancer patients.
Interferon gamma is used to treat chronic granulomatous disease and osteopetrosis
This report aims to provide a comprehensive presentation of the global market for Recombinant Cytokines Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Cytokines Drug. This report contains market size and forecasts of Recombinant Cytokines Drug in global, including the following market information:
Global Recombinant Cytokines Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Cytokines Drug Market Sales, 2018-2023, 2024-2029, (KG)
Global top five Recombinant Cytokines Drug companies in 2022 (%)
The global Recombinant Cytokines Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Interferon Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Cytokines Drug include Roche, Merck, Bayer, Biogen Idec, Gensci, Huaxin, Triprime, Sinovac and Zhaoke, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Cytokines Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Cytokines Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Recombinant Cytokines Drug Market Segment Percentages, by Type, 2022 (%)
Interferon
Recombinant Human Granulocyte Colony-Stimulating
Erythropoietin (EPO)
Recombinant Human Thrombopoietin
Others
Global Recombinant Cytokines Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Recombinant Cytokines Drug Market Segment Percentages, by Application, 2022 (%)
Hepatitis B
Hepatitis C
Multiple Sclerosis
Tumor Therapy
Wound Healing
Others
Global Recombinant Cytokines Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (KG)
Global Recombinant Cytokines Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Cytokines Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Cytokines Drug revenues share in global market, 2022 (%)
Key companies Recombinant Cytokines Drug sales in global market, 2018-2023 (Estimated), (KG)
Key companies Recombinant Cytokines Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Bayer
Biogen Idec
Gensci
Huaxin
Triprime
Sinovac
Zhaoke
Kawin
Abcam plc
R&D Systems
Thermo Fisher Scientific
BioLegend
Invitrogen
OriGene
Biorbyt
Qilu Pharmaceutical
Shijiazhuang Pharmaceutical
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Cytokines Drug, market overview.
Chapter 2: Global Recombinant Cytokines Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Cytokines Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Cytokines Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Cytokines Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Recombinant Cytokines Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Cytokines Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Cytokines Drug Overall Market Size
2.1 Global Recombinant Cytokines Drug Market Size: 2022 VS 2029
2.2 Global Recombinant Cytokines Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Cytokines Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Cytokines Drug Players in Global Market
3.2 Top Global Recombinant Cytokines Drug Companies Ranked by Revenue
3.3 Global Recombinant Cytokines Drug Revenue by Companies
3.4 Global Recombinant Cytokines Drug Sales by Companies
3.5 Global Recombinant Cytokines Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Cytokines Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Cytokines Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Cytokines Drug Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Cytokines Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Cytokines Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Cytokines Drug Market Size Markets, 2022 & 2029
4.1.2 Interferon
4.1.3 Recombinant Human Granulocyte Colony-Stimulating
4.1.4 Erythropoietin (EPO)
4.1.5 Recombinant Human Thrombopoietin
4.1.6 Others
4.2 By Type - Global Recombinant Cytokines Drug Revenue & Forecasts
4.2.1 By Type - Global Recombinant Cytokines Drug Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Cytokines Drug Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Cytokines Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Recombinant Cytokines Drug Sales & Forecasts
4.3.1 By Type - Global Recombinant Cytokines Drug Sales, 2018-2023
4.3.2 By Type - Global Recombinant Cytokines Drug Sales, 2024-2029
4.3.3 By Type - Global Recombinant Cytokines Drug Sales Market Share, 2018-2029
4.4 By Type - Global Recombinant Cytokines Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Cytokines Drug Market Size, 2022 & 2029
5.1.2 Hepatitis B
5.1.3 Hepatitis C
5.1.4 Multiple Sclerosis
5.1.5 Tumor Therapy
5.1.6 Wound Healing
5.1.7 Others
5.2 By Application - Global Recombinant Cytokines Drug Revenue & Forecasts
5.2.1 By Application - Global Recombinant Cytokines Drug Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Cytokines Drug Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Cytokines Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Recombinant Cytokines Drug Sales & Forecasts
5.3.1 By Application - Global Recombinant Cytokines Drug Sales, 2018-2023
5.3.2 By Application - Global Recombinant Cytokines Drug Sales, 2024-2029
5.3.3 By Application - Global Recombinant Cytokines Drug Sales Market Share, 2018-2029
5.4 By Application - Global Recombinant Cytokines Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Cytokines Drug Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Cytokines Drug Revenue & Forecasts
6.2.1 By Region - Global Recombinant Cytokines Drug Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Cytokines Drug Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Cytokines Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Recombinant Cytokines Drug Sales & Forecasts
6.3.1 By Region - Global Recombinant Cytokines Drug Sales, 2018-2023
6.3.2 By Region - Global Recombinant Cytokines Drug Sales, 2024-2029
6.3.3 By Region - Global Recombinant Cytokines Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Recombinant Cytokines Drug Revenue, 2018-2029
6.4.2 By Country - North America Recombinant Cytokines Drug Sales, 2018-2029
6.4.3 US Recombinant Cytokines Drug Market Size, 2018-2029
6.4.4 Canada Recombinant Cytokines Drug Market Size, 2018-2029
6.4.5 Mexico Recombinant Cytokines Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Recombinant Cytokines Drug Revenue, 2018-2029
6.5.2 By Country - Europe Recombinant Cytokines Drug Sales, 2018-2029
6.5.3 Germany Recombinant Cytokines Drug Market Size, 2018-2029
6.5.4 France Recombinant Cytokines Drug Market Size, 2018-2029
6.5.5 U.K. Recombinant Cytokines Drug Market Size, 2018-2029
6.5.6 Italy Recombinant Cytokines Drug Market Size, 2018-2029
6.5.7 Russia Recombinant Cytokines Drug Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Cytokines Drug Market Size, 2018-2029
6.5.9 Benelux Recombinant Cytokines Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Recombinant Cytokines Drug Revenue, 2018-2029
6.6.2 By Region - Asia Recombinant Cytokines Drug Sales, 2018-2029
6.6.3 China Recombinant Cytokines Drug Market Size, 2018-2029
6.6.4 Japan Recombinant Cytokines Drug Market Size, 2018-2029
6.6.5 South Korea Recombinant Cytokines Drug Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Cytokines Drug Market Size, 2018-2029
6.6.7 India Recombinant Cytokines Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Recombinant Cytokines Drug Revenue, 2018-2029
6.7.2 By Country - South America Recombinant Cytokines Drug Sales, 2018-2029
6.7.3 Brazil Recombinant Cytokines Drug Market Size, 2018-2029
6.7.4 Argentina Recombinant Cytokines Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Cytokines Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Recombinant Cytokines Drug Sales, 2018-2029
6.8.3 Turkey Recombinant Cytokines Drug Market Size, 2018-2029
6.8.4 Israel Recombinant Cytokines Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Cytokines Drug Market Size, 2018-2029
6.8.6 UAE Recombinant Cytokines Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Recombinant Cytokines Drug Major Product Offerings
7.1.4 Roche Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Recombinant Cytokines Drug Major Product Offerings
7.2.4 Merck Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Recombinant Cytokines Drug Major Product Offerings
7.3.4 Bayer Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Biogen Idec
7.4.1 Biogen Idec Company Summary
7.4.2 Biogen Idec Business Overview
7.4.3 Biogen Idec Recombinant Cytokines Drug Major Product Offerings
7.4.4 Biogen Idec Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.4.5 Biogen Idec Key News & Latest Developments
7.5 Gensci
7.5.1 Gensci Company Summary
7.5.2 Gensci Business Overview
7.5.3 Gensci Recombinant Cytokines Drug Major Product Offerings
7.5.4 Gensci Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.5.5 Gensci Key News & Latest Developments
7.6 Huaxin
7.6.1 Huaxin Company Summary
7.6.2 Huaxin Business Overview
7.6.3 Huaxin Recombinant Cytokines Drug Major Product Offerings
7.6.4 Huaxin Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.6.5 Huaxin Key News & Latest Developments
7.7 Triprime
7.7.1 Triprime Company Summary
7.7.2 Triprime Business Overview
7.7.3 Triprime Recombinant Cytokines Drug Major Product Offerings
7.7.4 Triprime Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.7.5 Triprime Key News & Latest Developments
7.8 Sinovac
7.8.1 Sinovac Company Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Recombinant Cytokines Drug Major Product Offerings
7.8.4 Sinovac Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.8.5 Sinovac Key News & Latest Developments
7.9 Zhaoke
7.9.1 Zhaoke Company Summary
7.9.2 Zhaoke Business Overview
7.9.3 Zhaoke Recombinant Cytokines Drug Major Product Offerings
7.9.4 Zhaoke Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.9.5 Zhaoke Key News & Latest Developments
7.10 Kawin
7.10.1 Kawin Company Summary
7.10.2 Kawin Business Overview
7.10.3 Kawin Recombinant Cytokines Drug Major Product Offerings
7.10.4 Kawin Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.10.5 Kawin Key News & Latest Developments
7.11 Abcam plc
7.11.1 Abcam plc Company Summary
7.11.2 Abcam plc Recombinant Cytokines Drug Business Overview
7.11.3 Abcam plc Recombinant Cytokines Drug Major Product Offerings
7.11.4 Abcam plc Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.11.5 Abcam plc Key News & Latest Developments
7.12 R&D Systems
7.12.1 R&D Systems Company Summary
7.12.2 R&D Systems Recombinant Cytokines Drug Business Overview
7.12.3 R&D Systems Recombinant Cytokines Drug Major Product Offerings
7.12.4 R&D Systems Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.12.5 R&D Systems Key News & Latest Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Company Summary
7.13.2 Thermo Fisher Scientific Recombinant Cytokines Drug Business Overview
7.13.3 Thermo Fisher Scientific Recombinant Cytokines Drug Major Product Offerings
7.13.4 Thermo Fisher Scientific Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.13.5 Thermo Fisher Scientific Key News & Latest Developments
7.14 BioLegend
7.14.1 BioLegend Company Summary
7.14.2 BioLegend Business Overview
7.14.3 BioLegend Recombinant Cytokines Drug Major Product Offerings
7.14.4 BioLegend Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.14.5 BioLegend Key News & Latest Developments
7.15 Invitrogen
7.15.1 Invitrogen Company Summary
7.15.2 Invitrogen Business Overview
7.15.3 Invitrogen Recombinant Cytokines Drug Major Product Offerings
7.15.4 Invitrogen Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.15.5 Invitrogen Key News & Latest Developments
7.16 OriGene
7.16.1 OriGene Company Summary
7.16.2 OriGene Business Overview
7.16.3 OriGene Recombinant Cytokines Drug Major Product Offerings
7.16.4 OriGene Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.16.5 OriGene Key News & Latest Developments
7.17 Biorbyt
7.17.1 Biorbyt Company Summary
7.17.2 Biorbyt Business Overview
7.17.3 Biorbyt Recombinant Cytokines Drug Major Product Offerings
7.17.4 Biorbyt Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.17.5 Biorbyt Key News & Latest Developments
7.18 Qilu Pharmaceutical
7.18.1 Qilu Pharmaceutical Company Summary
7.18.2 Qilu Pharmaceutical Business Overview
7.18.3 Qilu Pharmaceutical Recombinant Cytokines Drug Major Product Offerings
7.18.4 Qilu Pharmaceutical Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.18.5 Qilu Pharmaceutical Key News & Latest Developments
7.19 Shijiazhuang Pharmaceutical
7.19.1 Shijiazhuang Pharmaceutical Company Summary
7.19.2 Shijiazhuang Pharmaceutical Business Overview
7.19.3 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Major Product Offerings
7.19.4 Shijiazhuang Pharmaceutical Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.19.5 Shijiazhuang Pharmaceutical Key News & Latest Developments
7.20 Amgen
7.20.1 Amgen Company Summary
7.20.2 Amgen Business Overview
7.20.3 Amgen Recombinant Cytokines Drug Major Product Offerings
7.20.4 Amgen Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.20.5 Amgen Key News & Latest Developments
7.21 Johnson & Johnson
7.21.1 Johnson & Johnson Company Summary
7.21.2 Johnson & Johnson Business Overview
7.21.3 Johnson & Johnson Recombinant Cytokines Drug Major Product Offerings
7.21.4 Johnson & Johnson Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.21.5 Johnson & Johnson Key News & Latest Developments
7.22 Kyowa Hakko Kirin
7.22.1 Kyowa Hakko Kirin Company Summary
7.22.2 Kyowa Hakko Kirin Business Overview
7.22.3 Kyowa Hakko Kirin Recombinant Cytokines Drug Major Product Offerings
7.22.4 Kyowa Hakko Kirin Recombinant Cytokines Drug Sales and Revenue in Global (2018-2023)
7.22.5 Kyowa Hakko Kirin Key News & Latest Developments
8 Global Recombinant Cytokines Drug Production Capacity, Analysis
8.1 Global Recombinant Cytokines Drug Production Capacity, 2018-2029
8.2 Recombinant Cytokines Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Cytokines Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Cytokines Drug Supply Chain Analysis
10.1 Recombinant Cytokines Drug Industry Value Chain
10.2 Recombinant Cytokines Drug Upstream Market
10.3 Recombinant Cytokines Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Cytokines Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com